Parkinson’s disease (PD), the world’s second most prevalent neurodegenerative disorder, is characterized by progressive neuronal degeneration driven by complex pathological mechanisms. Phosphorylation signaling pathways have increasingly been recognized as critical modulators in PD development and progression. Meanwhile, short-chain fatty acids (SCFAs), primarily produced by gut microbiota, have demonstrated notable neuroprotective potential by promoting autophagy, alleviating mitochondrial dysfunction, and regulating neuroinflammatory responses. Emerging research suggests that SCFAs may influence the phosphorylation dynamics of key signaling pathways—including MAPKs, NF-κB, JAK/STAT, PI3K/Akt, AMPK, and Nrf2/Keap1/ARE—thereby modulating PD pathophysiology.
This review aims to systematically evaluate existing evidence on the interplay between SCFAs and these phosphorylation cascades, elucidating their roles in PD pathogenesis.
In addition to synthesizing current findings, this review proposes novel mechanistic hypotheses and outlines future research directions that may facilitate the identification of new molecular targets, offering valuable insights into therapeutic strategies and preventive interventions for PD.
If you have any questions about submitting your review, please email us at [email protected].